PRODIGIOSIN ENCAPSULATED POLY LACTIDE-CO-GLYCOLIDE (PLGA)-COATED STENT FOR CORONARY CARDIOVASCULAR INTERVENTIONS


PRODIGIOSIN ENCAPSULATED POLY LACTIDE-CO-GLYCOLIDE (PLGA)-COATED STENT FOR CORONARY CARDIOVASCULAR INTERVENTIONS

Type: Project Materials | Format: Ms Word | Attribute: Documentation Only | Pages: 50 Pages | Chapters: 1-5 chapters | Price: ₦ 3,000.00

1,704 marked this research material reliable.
Call or whatsapp: +2347063298784 or email: info@allprojectmaterials.com
PRODIGIOSIN ENCAPSULATED POLY LACTIDE-CO-GLYCOLIDE (PLGA)-COATED STENT FOR CORONARY CARDIOVASCULAR INTERVENTIONS

ABSTRACT

This research focuses on the design of a robust but flexible prodigiosin eluting stent coating for possible coronary cardiovascular implant. When coated with the drug embedded polymer matrix, the stent would be expected to dilate the vessel around the fatty blockages while the drug eluting polymer membrane delivers anti-proliferative drugs over a period of time to prevent the restenosis that otherwise would occur. The goal of this work is to incorporate anti-cancerous drug prodigiosin in the PLGA polymer matrix and then ascertain its release kinetics. In this research, Poly vinyl Pyrrolidone was used as a binder and cross-linker to create adhesion between the metallic stent strut and the drug encapsulated polymer matrix as well as between the polymer and the drug. This work also explores diffusion and degradation phenomena to explain the transport, dissemination, dispersion and absorption of drugs at the interface between the stent and the vessel wall. The expected results will then be discussed for potential applications via the incorporation of these prodigiosin-eluting stents for the treatment of coronary cardiovascular diseases.



CHAPTER ONE

1.0         BACKGROUND AND INTRODUCTION

Cardiovascular disease is currently the leading cause of death in Africa and the world at large, accounting for at least 30% of all death. One of the major causes of cardiovascular disease is arteriosclerosis. It is as a consequence of the build-up of fatty cells and tissues within blood vessels. In most cases, this built-up is not detected until complete blockage which prevents the flow of blood and subsequently leads to heart attack, stroke or death. The objective is to develop prodigiosin embedded polymer-coated cardiovascular stents that will successfully deliver drugs and bioactive agents to blood vessels and treat coronary cardiovascular diseases while at the same time preventing restenosis-the narrowing of the blood vessel after angioplastic procedure. The polymer earmarked for these biodegradable coating is poly lactic-co-glycolic acid (PLGA) because of it biocompatibility and high rate of biodegradation. Over the past decade, drug eluting stents have been used to treat arteriosclerosis. Essentially, the stent dilate the vessel around the fatty blockages while the drug eluting coatings deliver anti-cancer drugs to prevent the restenosis that otherwise would occur. However, the stents remain permanently in the blood vessels after the duration of drug elution. Furthermore, vessel irritation, endothelial dysfunction, vessel hypersensitivity and chronic inflammation at the site of implantation are critical parameters that have attracted serious attention. There is therefore a need for multi-component, multifunctional materials for novel cardiovascular stents whereby, one important function should be degradability of the polymer so that after degradation, a functional vessel wall is regenerated [1].

There is also an equal need for reasonable stent coatings that can degrade gradually and be absorbed slowly by the body without creating the afore-mentioned adverse side effects.

1.1         STATEMENT OF THE PROBLEM

Cardiovascular disease (CVD) is a result of the disorder of the heart and blood vessels. Atherosclerosis, the main cause of coronary artery disease (CAD), is an inflammatory disease in which immune mechanisms interact with metabolic risk factors to initiate, propagate and activate lesions in the arterial wall [2]. About two decades ago, it was widely expected that the treatment of hypercholesterolemia and hypertension would eliminate CADs by the end of the 20th century but this has not been the case. CVDs include coronary heart disease (heart attacks), cerebrovascular disease (stroke), high blood pressure (hypertension), peripheral artery disease, rheumatic heart disease, congenital heart disease, and heart failures [3]. The first two are the foremost causes of death in Africa and the world over. In 2008, about 17.3 million deaths were as a result of cardiovascular diseases. These represented 30% of the global death toll in 2008. Out of this figure, 7.3 million were due to coronary artery disease (Atherosclerosis), 6.2 million were due to stroke and 5.8 million were jointly caused by hypertension, high blood pressure, diabetes, and heart failure. Moreover, Coronary Artery Disease (CAD) is the principal cause of death in both males and females in the low-income and high-income countries. There is, therefore, an urgent need for improved approaches for the treatment of CAD in both developed developing and underdeveloped countries. People in low and middle-income countries are usually more exposed to risk factors of CVDs and do not often benefit from prevention programs as do people in high-income countries

PRODIGIOSIN ENCAPSULATED POLY LACTIDE-CO-GLYCOLIDE (PLGA)-COATED STENT FOR CORONARY CARDIOVASCULAR INTERVENTIONS

Additional Information

  • The Project Material is available for download.
  • The Research material is delivered within 15-30 Minutes.
  • The Material is complete from Preliminary Pages to References.
  • Well Researched and Approved for supervision.
  • Click the download button below to get the complete project material.

Frequently Asked Questions

In-order to give you the best service available online, we have compiled frequently asked questions (FAQ) from our clients so as to answer them and make your visit much more interesting.

We are proudly Nigerians, and we are well aware of fraudulent activities that has been ongoing in the internet. To make it well known to our customers, we are geniune and duely registered with the Corporate Affairs Commission of the republic of Nigeria. Remember, Fraudulent sites can NEVER post bank accounts or contact address which contains personal information. Free chapter One is always given on the site to prove to you that we have the material. If you are unable to view the free chapter 1 send an email to info@allprojectmaterials.com with the subject head "FREE CHAPTER 1' plus the topic. You will get a free chapter 1 within an hour. You can also check out what our happy clients have to say.


Students are always advised to use our materials as guide. However, if you have a different case study, you may need to consult one of our professional writers to help you with that. Depending on similarity of the organization/industry you may modify if you wish.


We have professional writers in various disciplines. If you have a fresh topic, just click Hire a Writer or click here to fill the form and one of our writers will contact you shortly.


Yes it is a complete research project. We ensure that our client receives complete project materials which includes chapters 1-5, full references, questionnaires/secondary data, etc.


Depending on how fast your request is acknowledged by us, you will get the complete project material withing 15-30 minutes. However, on a very good day you can still get it within 5 minutes!

What Clients Say

Our Researchers are happy, see what they are saying. Share your own experience with the world.
Be polite and honest, as we seek to expand our business and reach more people. Thank you.

A Research proposal for prodigiosin encapsulated poly lactide-co-glycolide (plga)-coated stent for coronary cardiovascular interventions:
A Review on prodigiosin encapsulated poly lactide-co-glycolide (plga)-coated stent for coronary cardiovascular interventions, prodigiosin, encapsulated, poly project topics, researchcub.info, project topic, list of project topics, research project topics, journals, books, Academic writer.
This research focuses on the design of a robust but flexible prodigiosin eluting stent coating for possible coronary cardiovascular implant. When coated with the drug embedded polymer matrix, the stent would be expected to dilate the vessel around the fatty blockages while the drug eluting polymer membrane delivers anti-proliferative drugs over a period of time to prevent the restenosis that otherwise would occur. The goal of this work is to incorporate anti-cancerous drug prodigiosin in the PLGA polymer matrix and then ascertain its release kinetics. In this research, Poly vinyl Pyrrolidone was used as a binder and cross-linker to create adhesion between the metallic stent strut and the drug encapsulated polymer matrix as well as between the polymer and the drug. This work also explores diffusion and degradation phenomena to explain the transport, dissemination, dispersion and absorption of drugs at the interface between the stent and the vessel wall. The expected results will then be discussed for potential applications via the incorporation of these prodigiosin-eluting stents for the treatment of coronary cardiovascular diseases... physical science project topics

PRODIGIOSIN ENCAPSULATED POLY LACTIDE-CO-GLYCOLIDE (PLGA)-COATED STENT FOR CORONARY CARDIOVASCULAR INTERVENTIONS

Project Information

  • CATEGORY : PHYSICAL SCIENCE
  • TYPE : PROJECT MATERIAL
  • FORMAT : MICROSOFT WORD
  • ATTRIBUTE : Documentation Only
  • PAGES : 50 Pages
  • CHAPTERS : 1 - 5
  • PRICE : ₦ 3,000.00

Share Links

Download Post
Download Post

Search for Project Topics

Project topics in Departments

Do you need a writer for your academic work?